Collateral for a security interest recorded Nov 10, 2014 (Redpath Equityholder Representative, LLC).
Term ends Mar 19, 2033 · High confidence
20-year base term ends Dec 3, 2032
Filed Jul 30, 2013 as application 13/954,247 · Granted Nov 20, 2018
Base term plus 106 days of patent term adjustment (USPTO delay)
Today
2012
2033
Clock starts
Dec 3, 2012
Dec 3, 2012
Term ends
Mar 19, 2033
Mar 19, 2033
Granted
Nov 20, 2018
Nov 20, 2018
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
106
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 106 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 3, 2012, when application 13/692,727, the earliest non-provisional in its chain, was filed (this one was filed Jul 30, 2013) | Dec 3, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +106 days, USPTO patent term adjustment record | Mar 19, 2033 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 19, 2033 | High confidence |
This family
| US 10,255,410 | In force Jan 2033 | Jan 2033 |
| US 10,131,942 | this patent Mar 2033 | Mar 2033 |
| Application PCT/US2014/046702 | PCT application no patent term | no patent term |
| Application 16/166,486 | Abandoned not computed | not computed |
| US 12,205,676 | In force Jan 2033 | Jan 2033 |
| Application 18/989,610 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 11, 2013 Reel 31181, frame 350 | Ellsworth, Eric Matthew Gayle; Finkelstein, Sydney David; Jackson, Sara Ann; Corcoran, Brendan; Smith, Dennis Morgan, JR. | Redpath Integrated Pathology, Inc. | Assignment of Assignor's Interest |
| Mar 31, 2014 Reel 32564, frame 363 | Redpath Integrated Pathology, Inc. | Square 1 Bank | Security Interest |
| Oct 15, 2014 Reel 33954, frame 960 | Finkelstein, Sydney David | Redpath Integrated Pathology, Inc. | Assignment of Assignor's Interest |
| Oct 15, 2014 Reel 33955, frame 46 | Ellsworth, Eric Matthew Gayle | Redpath Integrated Pathology, Inc. | Assignment of Assignor's Interest |
| Oct 15, 2014 Reel 33955, frame 95 | Jackson, Sara Ann | Redpath Integrated Pathology, Inc. | Assignment of Assignor's Interest |
| Oct 15, 2014 Reel 33955, frame 142 | Corcoran, Brendan; Smith, Dennis Morgan, JR. | Redpath Integrated Pathology, Inc. | Assignment of Assignor's Interest |
| Oct 31, 2014 Reel 34083, frame 805 | Square 1 Bank | Redpath Integrated Technology, Inc. | Release of Security Interest |
| Nov 6, 2014 Reel 34114, frame 658 | Redpath Integrated Pathology, Inc.; Redpath Acquisition Sub, Inc.; Interpace Diagnostics Corporation | Interpace Diagnostics Corporation | Merger and Change of Name |
| Nov 10, 2014 Reel 34136, frame 312 | Interspace Diagnostics Corporation | Redpath Equityholder Representative, LLC | Security Interest |
| Nov 18, 2014 Reel 34202, frame 192 | Interpace Diagnostics Corporation | SWK Funding LLC, as Agent | Security Interest |
| Feb 22, 2016 Reel 37783, frame 678 | SWK Funding LLC | Interpace Diagnostics Corporation | Release of Security Interest |
| Sep 23, 2016 Reel 40125, frame 251 | Pdi, Inc.; Group Dca, LLC; Interpace Biopharma, LLC; Interpace Diagnostics, LLC; JS Genetics, Inc.; Redpath Acquisition Sub, Inc. | Redpath Equityholder Representative, LLC | Guarantee and Collateral Agreement |
| Sep 23, 2016 Reel 40127, frame 18 | Interpace Diagnostics Corporation; Pdi, Inc.; Group Dca, LLC; Interpace Biopharma, LLC; Interpace Diagnostics, LLC; JS Genetics, Inc. | Redpath Equityholder Representative, LLC | Joinder to Guarantee and Collateral Assignment |
| Mar 27, 2017 Reel 41754, frame 517 | Interpace Diagnostics Group, Inc. | Hudson Bay Master Fund Ltd. | Security Interest |
| Jun 16, 2017 Reel 42840, frame 860 | Hudson Bay Master Fund Ltd. | Interpace Diagnostics Group, Inc.; Interpace Biopharma, LLC; Interpace Diagnostics, LLC; Interpace Diagnostics Lab, Inc.; Interpace Diagnostics Corporation | Release of Security Interest |
| Jun 16, 2017 Reel 42856, frame 799 | Hudson Bay Master Fund Ltd. | Interpace Diagnostics Group, Inc.; Interpace Diagnostics, LLC; Interpace Diagnostics Corporation | Release of Security Interest |
| Jun 16, 2017 Reel 42858, frame 971 | Hudson Bay Master Fund Ltd. | Interpace Diagnostics Corporation | Release of Security Interest |
| Jun 16, 2017 reel/frame not recorded | Hudson Bay Master Fund Ltd. | Interpace Diagnostics Group, Inc. | Release of Security Interest |
| Jun 16, 2017 reel/frame not recorded | Hudson Bay Master Fund Ltd. | Interpace Biopharma, LLC | Release of Security Interest |
| Jun 16, 2017 reel/frame not recorded | Hudson Bay Master Fund Ltd. | Interpace Diagnostics, LLC | Release of Security Interest |
| Jun 16, 2017 reel/frame not recorded | Hudson Bay Master Fund Ltd. | Interpace Diagnostics Lab, Inc. | Release of Security Interest |
| Oct 20, 2021 Reel 57851, frame 289 | Interpace Diagnostics Corporation | Comerica Bank | Security Interest |
| Nov 2, 2021 Reel 57988, frame 110 | Interpace Biosciences, Inc.; Interpace Diagnostics Corporation; Interpace Diagnostics, LLC; Interpace Pharma Solutions, Inc. | Broadoak Fund V, L.p. | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2033
Term ends Mar 19, 2033. Maintenance fees still fall due before then
Note
The 106 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
That is below the median of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.